» Articles » PMID: 10758967

Development and Evaluation of the Kansas City Cardiomyopathy Questionnaire: a New Health Status Measure for Heart Failure

Overview
Date 2000 Apr 12
PMID 10758967
Citations 644
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To create a valid, sensitive, disease-specific health status measure for patients with congestive heart failure (CHF).

Background: Quantifying health status is becoming increasingly important for CHF. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life.

Methods: To establish the performance characteristics of the KCCQ, two distinct patient cohorts were recruited: 70 stable and 59 decompensated CHF patients with ejection fractions of <40. Upon entry into the study, patients were administered the KCCQ, the Minnesota Living with Heart Failure Questionnaire and the Short Form-36 (SF-36). Questionnaires were repeated three months later.

Results: Convergent validity of each KCCQ domain was documented by comparison with available criterion standards (r = 0.46 to 0.74; p < 0.001 for all). Among those with stable CHF who remained stable by predefined criteria (n = 39), minimal changes in KCCQ domains were detected over three months of observation (mean change = 0.8 to 4.0 points, p = NS for all). In contrast, large changes in score were observed among patients whose decompensated CHF improved three months later (n = 39; mean change = 15.4 to 40.4 points, p < 0.01 for all). The sensitivity of the KCCQwas substantially greater than that of the Minnesota Living with Heart Failure and the SF-36 questionnaires.

Conclusions: The KCCQis a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment.

Citing Articles

Cardiopulmonary exercise capacity markers and their link to symptom burden in patients at risk for heart failure with non-reduced ejection fraction.

Kwast S, Hoffmann J, Pokel C, Falz R, Schulze A, Schroter T Sci Rep. 2025; 15(1):8940.

PMID: 40089637 DOI: 10.1038/s41598-025-94172-1.


A systematic review to identify assessment instruments for social isolation or loneliness in adults with heart failure.

William S, McDonagh J, Allida S, Kasa A, Patterson C, Deek H NPJ Cardiovasc Health. 2025; 2(1):10.

PMID: 40061843 PMC: 11888987. DOI: 10.1038/s44325-025-00044-y.


The evaluation of clinical outcomes assessments and digital health technologies in clinical trials for obesity.

Goetz I, Sutter C, Abraham T, Kanu C, Boye K, Symonds T J Patient Rep Outcomes. 2025; 9(1):23.

PMID: 39976863 PMC: 11842654. DOI: 10.1186/s41687-025-00841-0.


Acceptance of Illness and Health-Related Quality of Life in Patients After Myocardial Infarction-Narrative Review.

Tokarewicz J, Jankowiak B, Klimaszewska K, Swieczkowski M, Matlak K, Dobrzycki S J Clin Med. 2025; 14(3).

PMID: 39941398 PMC: 11818487. DOI: 10.3390/jcm14030729.


Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.

Barnard-Kelly K, Battelino T, Brosius F, Ceriello A, Cosentino F, Gavin 3rd J Cardiovasc Diabetol. 2025; 24(1):68.

PMID: 39920737 PMC: 11806799. DOI: 10.1186/s12933-024-02550-2.